[ad_1]
The European Commission said on Tuesday that it approved the $62-billion (48.2 billion pounds) takeover of London’s Shire plc by Takeda Pharmaceutical of Japan, subject to the divestment of a Shire drug in development.



[ad_2]
Source link



Leave a Reply